Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Thematic ETFs

GNMX vs GNOM: Holdings Overlap & Returns

Share
Share on XDownload as PDF

GNMX and GNOM hold 44% of their weight in the same names.

askIQ about this page

askIQ about GNMX and GNOM

Net assets: $1.3m on Nov 4, 2026 for Corgi Genomics & Precision Medicine ETF, and $104m on Oct 12, 2026 for Global X Genomics & Biotechnology ETF.

At a glance
31.0%
GNMX in the S&P 500
21.0%
GNOM in the S&P 500
+48.3%
GNMX total return, 6 months
+66.6%
GNOM total return, 1 year
GNMX · 6 months to Nov 4, 2026 69% of its weight is outside the S&P 500
69% of its weight is outside the S&P 50031% of GNMX's weight is in S&P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026.31%69%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 99% · top ten 49% of the fund · 57 holdings as published by its issuer for Nov 4, 2026 · Nasdaq-100: 8% in69% of its weight is outside the S&P 50031% of GNMX's weight is in S&P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026.31%69%inoutside the S&P 500active share 99% · Nasdaq-100: 8% in

31% of GNMX's weight is in S&P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026.

GNOM · 1 year to Nov 4, 2026 79% of its weight is outside the S&P 500
79% of its weight is outside the S&P 50021% of GNOM's weight is in S&P 500 companies and 79% is outside the index. Holdings as of Aug 31, 2026.21%79%in the S&P 500of its weight outside the S&P 500active share 98% · top ten 49% of the fund · 50 holdings as filed for Aug 31, 2026 · Nasdaq-100: 5% in79% of its weight is outside the S&P 50021% of GNOM's weight is in S&P 500 companies and 79% is outside the index. Holdings as of Aug 31, 2026.21%79%inoutside the S&P 500active share 98% · Nasdaq-100: 5% in

21% of GNOM's weight is in S&P 500 companies and 79% is outside the index. Holdings as of Aug 31, 2026.

Pair scorecard

GNMX costs 0.15 points a year less; GNOM is far larger, $104m against $1.3m.

GNMX vs GNOM: Holdings Overlap & Returns
MeasureGNMXGNOM
Return
Total return, 1 yearnot published+66.6%
Drawdown
Below its all-time high36.2%, high on Feb 8, 2021
Benchmark
What it tracksGenomics and gene editingGenomics and gene editing
Cost and size
Expense ratio0.35%0.50%
Net assets, as of Oct 12, 2026$1.3m$104m
Holdings
Holdings in common44%

Method

What they share

44%

By the books each fund has filed, GNMX and GNOM hold 44% of their money in the same securities at the same weight. Holdings dated Aug 31, 2026 and Nov 4, 2026.

0 half 100%

half

44% in common

Positions both hold · largest shared weight first GNMX GNOM
Moderna Inc 11.24% 7.50%
Illumina Inc 3.92% 4.87%
Vertex Pharmaceuticals Inc 6.04% 3.70%
Guardant Health Inc 3.45% 5.28%
10X Genomics Inc 2.87% 5.48%
Twist Bioscience Corp 2.32% 6.34%
Bio-Techne Corp 2.10% 3.67%
QIAGEN NV 2.08% 3.22%
BioMarin Pharmaceutical Inc 1.89% 3.58%
CareDx Inc 2.43% 1.78%
Veracyte Inc 1.46% 2.61%
Caris Life Sciences Inc 1.39% 2.38%
Only in one fund ↓
Only in GNMX
Thermo Fisher Scientific Inc 8.88%
Genmab A/S 4.39%
Revolution Medicines Inc 3.24%
Incyte Corp 2.70%
GRAIL Inc 2.26%
Iovance Biotherapeutics Inc 1.86%
Tempus AI Inc 1.86%
Alnylam Pharmaceuticals Inc 1.69%
Only in GNOM
NATERA, INC. 4.61%
Genscript Biotech Corp 3.81%
Praxis Precision Medicines, Inc. 3.09%
BioNTech SE 2.78%
Legend Biotech Corporation 2.38%
ELI LILLY AND COMPANY 1.85%
GILEAD SCIENCES, INC. 1.64%
BillionToOne, Inc. 1.39%
Check overlap with more funds →

Window by window

Window by window: GNMX vs GNOM: Holdings Overlap & Returns
Total return
WindowGNMXGNOM
3 months+24.3%+24.5%
6 months+48.3%+49.4%
1 year–+66.6%
3 years–+81.6%
Since launchNot the same days: GNMX May 2026 · GNOM Apr 2019+48.3%+16.0%

– means no data for this window. Open this comparison in the app →

Side by side

GNMX Corgi Genomics & Precision Medicine ETF · Holds 57 stocks in genomics and gene editing, 31% of its weight in S&P 500 companies GNOM Global X Genomics & Biotechnology ETF · Holds 50 stocks in genomics and gene editing, 21% of its weight in S&P 500 companies
Theme Genomics and gene editing Genomics and gene editing
In the S&P 500 31.0% 21.0%
Active share vs the S&P 500 99.4% 97.6%
In the Nasdaq-100 7.7% 5.3%
Holdings 57 50
Top ten, share of the fund 49.2% 48.8%
Expense ratio 0.35% 0.50%
Fee for the differing part 0.35% 0.51%
Total return, 1 year +48.3% (since launch, May 6, 2026) +66.6%
vs its benchmark not measured not measured
Below its high −4.2% −36.2%
Net assets, GNMX as of Nov 4, 2026 and GNOM as of Oct 12, 2026 $1.3m $104m

As of Nov 4, 2026. Source: ETFIQ.

44% of the two portfolios are the same securities at the same weight.

Alert

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
GNMX

By weight, 31% of GNMX's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 49% of the fund across 57 positions, as published by its issuer for Nov 4, 2026. Since it first traded on May 6, 2026 the fund returned +48.3% with distributions reinvested.

GNOM

By weight, 21% of GNOM's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 49% of the fund across 50 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +66.6% with distributions reinvested. It sits 36.2% below its all-time high of Feb 8, 2021.

Questions people ask

Do GNMX and GNOM hold the same stocks?
By their latest filings, 44% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, GNMX or GNOM?
GNMX has 31% of its weight in S&P 500 names and GNOM has 21%, so GNMX differs more from the index.
Which is cheaper, GNMX or GNOM?
GNMX charges 0.35% a year and GNOM charges 0.50%, so GNMX is cheaper. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, GNMX against GNOM, data as of Nov 4, 2026. https://etfiq.com/compare/themes/gnmx-vs-gnom

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.